Search by Drug Name or NDC
NDC 62856-0584-46 Banzel 40 mg/mL Details
Banzel 40 mg/mL
Banzel is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eisai Inc.. The primary component is RUFINAMIDE.
MedlinePlus Drug Summary
Rufinamide is used with other medication(s) to control seizures in people who have Lennox-Gastaut syndrome (a severe form of epilepsy that begins during childhood and causes several types of seizures, behavioral disturbances, and developmental delays). Rufinamide is in a class of medications called anticonvulsants. It works by decreasing abnormal excitement in the brain.
Related Packages: 62856-0584-46Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Rufinamide
Product Information
| NDC | 62856-0584 |
|---|---|
| Product ID | 62856-584_e2b636a9-79ad-4804-b5f9-c9be2713e84b |
| Associated GPIs | 72600065001820 |
| GCN Sequence Number | 067131 |
| GCN Sequence Number Description | rufinamide ORAL SUSP 40 MG/ML ORAL |
| HIC3 | H4B |
| HIC3 Description | ANTICONVULSANTS |
| GCN | 29462 |
| HICL Sequence Number | 034982 |
| HICL Sequence Number Description | RUFINAMIDE |
| Brand/Generic | Brand |
| Proprietary Name | Banzel |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | rufinamide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 40 |
| Active Ingredient Units | mg/mL |
| Substance Name | RUFINAMIDE |
| Labeler Name | Eisai Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA201367 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62856-0584-46 (62856058446)
| NDC Package Code | 62856-584-46 |
|---|---|
| Billing NDC | 62856058446 |
| Package | 1 BOTTLE in 1 CARTON (62856-584-46) / 460 mL in 1 BOTTLE |
| Marketing Start Date | 2011-03-03 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 3.67035 |
| Pricing Unit | ML |
| Effective Date | 2023-05-17 |
| NDC Description | BANZEL 40 MG/ML SUSPENSION |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis